雷帕霉素洗脱支架在冠心病合并糖尿病患者中的疗效观察
出处
《中国误诊学杂志》
CAS
2007年第5期975-976,共2页
Chinese Journal of Misdiagnostics
参考文献6
-
1赵倡武,李传昶,李其富.雷帕霉素支架预防支架内再狭窄的临床效果[J].中原医刊,2006,33(2):40-41. 被引量:2
-
2Leon MB,Hohnes D,Simonton C,et al.The impact sirolimus-eluting stems in diabetics:results from the SIBILS Trial[J].Am Coll Cardiol,2003,41:54A.
-
3Kugelmass AD,Cohen DJ,Houser F,et al.The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community:a report from the HCA database[J].J Invasive Cardiol,2003,15(10):568-574.
-
4胡允兆,周艺,卢剑华,何宗云,吴炎贤.雷帕霉素洗脱支架治疗冠心病并糖尿病的临床疗效观察[J].实用医学杂志,2005,21(17):1949-1950. 被引量:2
-
5苏林,刘学波,葛均波.糖尿病与冠脉支架再狭窄的关系分析[J].中国临床医学,2005,12(4):578-580. 被引量:19
-
6Morice MC,Serruys PW,Sousa JP,et al.A randomized compaision of a sirolimus eluting stent with a standard stent for coronary revascularization[J].N Pnnl J Med,2002,341:1773-1780.
二级参考文献18
-
1Sousa JE,Abizaid AC,et al.Late (two years) follow-up from the firstin-man experience after implantation of sirolimus-eluting stent.J Am Coll Cardiol,2002,39-21.
-
2Tanner EC,Yang ZY,Dukers E,et al.Expression of cylin dependent kinnase inhibitors in vascular disease.Circ Res,1998.83.
-
3Hausleiter J,Sebastion M,Li AN,et al.A porcine coronary stent model of increased neointima formation in the left anterior descending coronary artery.Z Kardiol,2002,91:614 ~619.
-
4Schwarts SM.Smooth muscle migration in atherosclerosis and restenosis.J Clin Invest,1997,100:587 ~ 589.
-
5Kugelmass AD, Cohen DJ, Houser F, et al. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database. J Invasive Cardiol, 2003, 15 ( 10 ) : 568 - 574.
-
6Mathew V, C.ersh B J, Williams BA, et al. Outcomes in patients with diabetes mellitus undergoing parcutaneous coronary intervention in the current era: a report from the Prevention of REStenesis with Tranilast and its Outcomes (PRESTO) trial Circulation, 2004, 109(4): 476 - 480.
-
7Steven O, Andrew R. The development of rapamycin and its application to stent restenosis. Circulation, 2001, 104 (8) : 852-855.
-
8Holmes DR Jr, Leon MB, Moses J-W, et al. Analysis of 1-years clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation, 2004, 109(5):634-640.
-
9Leon MB, Holmes D, Simonton C, et al. The impact of simlimus-eluting stents indiabetics: results from the SIRIUS Trial. J Am Coll Cardiol, 2003,41(suppl 6A):54A.
-
10雷寒 陈玉国 马康华.冠状动脉再狭窄的病理生理与临床评价[A].见:马长生著.介入心脏病学[C].人民卫生出版社,1999,9.64-71.
共引文献20
-
1张凯,陈志强.冠状动脉支架置入术后再狭窄的影响因素[J].国际心血管病杂志,2006,33(6):381-383.
-
2郑喜胜,李纲,韩学华,李玉东,裴晓宁.糖尿病患者PCI术后血糖的分析[J].医学信息(西安上半月),2007,20(3):468-469.
-
3丘向艳.老年2型糖尿病合并冠心病心力衰竭107例[J].实用医学杂志,2007,23(15):2410-2411. 被引量:8
-
4佟翠艳,刘剑立,刘雪虹.老年冠心病冠脉支架再狭窄相关因素调查[J].解放军保健医学杂志,2007,9(4):215-217. 被引量:7
-
5佟翠艳,刘剑立,刘雪虹.老年冠心病冠脉病变特点及再狭窄相关因素分析[J].沈阳部队医药,2008,21(2):78-79. 被引量:2
-
6苏海燕,潘长玉,刘敏,金萌萌.空腹血糖水平与经皮冠状动脉介入治疗五年预后的关系[J].中华心血管病杂志,2008,36(8):710-713. 被引量:10
-
7郑权秀,加藤修,史东.糖尿病对大管径冠状动脉支架再狭窄率的影响[J].天津医药,2008,36(9):673-675.
-
8纪军,何胜虎.糖耐量异常对冠心病支架植入术后主要心脏事件的影响[J].中国基层医药,2008,15(12):1946-1947. 被引量:4
-
9张艳,李乐雯,钟书辉,贝筝,习隽丽.冠状动脉支架涂层材料对置入后发生血管再狭窄的影响[J].中国组织工程研究与临床康复,2010,14(34):6405-6408. 被引量:4
-
10卢英民,黄达民,张颖,姚能才,窦存芳,杨森畅,石来新,张金春,季俭,沈俊娴,包敏敏,李毅刚.运动训练对大管径冠状动脉支架再狭窄率的影响[J].心血管康复医学杂志,2011,20(5):416-419. 被引量:2
-
1谢芳.04084 西罗莫司与肺炎有关联[J].国外药讯,2001(4):35-35.
-
2曹道俊.雷帕霉素洗脱支架与金属裸支架的临床对照观察[J].中国误诊学杂志,2007,7(25):6031-6032. 被引量:1
-
3王景斌.雷帕霉素洗脱支架与金属裸支架的临床对照研究[J].中国实用医刊,2008,35(3):6-8.
-
4袁超,吴婕.雷帕霉素洗脱支架治疗左主干病变冠心病患者的临床疗效[J].中国实用医药,2015,10(24):170-171. 被引量:1
-
5韩雅君,田志强,赵平.极晚期西罗莫司药物洗脱支架后冠状动脉瘤伴血栓事件三例[J].中华临床医师杂志(电子版),2013,7(11):212-212.
-
6张现朝,孙晓斐,丛培玲,任长杰,武宗寅,王海明.药物洗脱支架与普通支架在冠心病合并2型糖尿病患者中的临床疗效比较[J].中国介入心脏病学杂志,2006,14(6):380-380.
-
7黎忠信,谢莉.无痛胃镜检查的初步经验[J].中华腹部疾病杂志,2006,6(12):900-901. 被引量:2
-
8许家琍,江洪,王晋明,张庆华,陈远秀,漆曙辉.床旁冠脉内溶栓治疗急性心肌梗塞的临床报告[J].中国急救医学,1993,13(5):31-32. 被引量:1
-
9姜晓飞.雷帕霉素洗脱支架在老年STEMI患者冠状动脉介入术中的应用效果[J].基层医学论坛,2016,20(29):4074-4075. 被引量:1
-
10赵瑞,高玉婷,蔡晓庆,段玉彩,李梦薇.冠心病患者PCI术后完全性左束支传导阻滞消失1例[J].心脏杂志,2016,0(3).